Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy
- PMID: 20110379
- PMCID: PMC2844306
- DOI: 10.1681/ASN.2009080861
Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy
Abstract
Spontaneous remission is a well known characteristic of idiopathic membranous nephropathy, but contemporary studies describing predictors of remission and long-term outcomes are lacking. We conducted a retrospective, multicenter cohort study of 328 patients with nephrotic syndrome resulting from idiopathic membranous nephropathy that initially received conservative therapy. Spontaneous remission occurred in 104 (32%) patients: proteinuria progressively declined after diagnosis until remission of disease at 14.7 +/- 11.4 months. Although spontaneous remission was more frequent with lower levels of baseline proteinuria, it also frequently occurred in patients with massive proteinuria: 26% among those with baseline proteinuria 8 to 12 g/24 h and 22% among those with proteinuria >12 g/24 h. Baseline serum creatinine and proteinuria, treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists, and a >50% decline of proteinuria from baseline during the first year of follow-up were significant independent predictors for spontaneous remission. Only six patients (5.7%) experienced a relapse of nephrotic syndrome. The incidence of death and ESRD were significantly lower among patients with spontaneous remission. In conclusion, spontaneous remission is common among patients with nephrotic syndrome resulting from membranous nephropathy and carries a favorable long-term outcome with a low incidence of relapse. A decrease in proteinuria >50% from baseline during the first year predicts spontaneous remission.
Figures




Comment in
-
Idiopathic membranous nephropathy: getting better by itself.J Am Soc Nephrol. 2010 Apr;21(4):551-2. doi: 10.1681/ASN.2010020185. Epub 2010 Mar 18. J Am Soc Nephrol. 2010. PMID: 20299357 No abstract available.
Similar articles
-
Factors affecting the long-term outcomes of idiopathic membranous nephropathy.BMC Nephrol. 2017 Mar 27;18(1):104. doi: 10.1186/s12882-017-0525-6. BMC Nephrol. 2017. PMID: 28347297 Free PMC article.
-
Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.Nephrol Dial Transplant. 2012 Jan;27(1):231-4. doi: 10.1093/ndt/gfr285. Epub 2011 May 30. Nephrol Dial Transplant. 2012. PMID: 21624942
-
Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.Nephrol Dial Transplant. 1989;4(6):525-9. Nephrol Dial Transplant. 1989. PMID: 2507973
-
Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy?J Nephrol. 2010 Mar-Apr;23(2):156-63. J Nephrol. 2010. PMID: 20213607 Review.
-
Treatment of the nephrotic syndrome with cyclosporin A.J Autoimmun. 1992 Apr;5 Suppl A:315-24. doi: 10.1016/0896-8411(92)90049-v. J Autoimmun. 1992. PMID: 1503627 Review.
Cited by
-
Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.Nephron Extra. 2011 Jan;1(1):251-61. doi: 10.1159/000333068. Epub 2011 Dec 24. Nephron Extra. 2011. PMID: 22470399 Free PMC article.
-
How many podocyte autophagosomes are there in immunoglobulin A nephropathy and idiopathic membranous nephropathy?Int Urol Nephrol. 2016 Dec;48(12):2109-2114. doi: 10.1007/s11255-016-1398-5. Epub 2016 Aug 31. Int Urol Nephrol. 2016. PMID: 27580730
-
Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab.J Nephrol. 2021 Apr;34(2):603-606. doi: 10.1007/s40620-020-00874-2. Epub 2020 Oct 7. J Nephrol. 2021. PMID: 33026632 Free PMC article.
-
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia.Front Immunol. 2022 Mar 1;13:789713. doi: 10.3389/fimmu.2022.789713. eCollection 2022. Front Immunol. 2022. PMID: 35300332 Free PMC article. Review.
-
Efficacy and safety of rituximab for primary membranous nephropathy with different clinical presentations: a retrospective study.Front Immunol. 2023 Apr 28;14:1156470. doi: 10.3389/fimmu.2023.1156470. eCollection 2023. Front Immunol. 2023. PMID: 37187749 Free PMC article.
References
-
- Fervenza FC, Sethi S, Specks U: Idiopathic membranous nephropathy: Diagnosis and treatment. Clin J Am Soc Nephrol 3: 905– 919, 2008 - PubMed
-
- Cattran DC: Idiopathic membranous nephropathy. Kidney Int 59: 1983– 1994, 2001 - PubMed
-
- Rivera F, López-Gómez JM, Pérez García R: Clinicopathological correlations of renal pathology in Spain. Kidney Int 66: 898– 904, 2004 - PubMed
-
- Coggins CH. for the Collaborative Study of the Adult Idiopathic Nephrotic Syndrome A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301: 1301– 1306, 1979 - PubMed
-
- Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B, Sasdelli M, Locatelli F: A randomized trial of methylprednisone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320: 8– 13, 1989 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical